Frequency Therapeutics

About:

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

Website: http://www.frequencytx.com/index.php

Twitter/X: frequencytx

Top Investors: Alexandria Venture Investments, Perceptive Advisors, RTW Investments, Alexandria Real Estate Equities, U.S. Department of Defense

Description:

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.

Total Funding Amount:

$118M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2015-01-01

Contact Email:

frequencytx(AT)macbiocom.com

Founders:

Chris Loose, Dan O’Neill, David L. Lucchino, Jeff Karp, Will McLean

Number of Employees:

51-100

Last Funding Date:

2022-08-15

IPO Status:

Public

Industries:

© 2025 bioDAO.ai